ATLANTA -- Adults who are at high risk of becoming infected with the human immunodeficiency virus (HIV), which causes AIDS,...
ATLANTA -- A common single nucleotide polymorphism (SNP) was associated with increased risk for developing stroke in childhood survivors who...
ATLANTA -- Maintenance treatment with the PARP inhibitor rucaparib (Rubraca) was well tolerated and provided clinical responses among patients with...
ATLANTA -- Prostate cancer incidence and mortality rates are decreasing or stabilizing in most parts of the world, with the...
ATLANTA -- Surgery was associated with higher survival rates for patients with HER2-positive (HER2+) stage 4 breast cancer compared with...
Data presented in a news conference at AACR Annual Meeting ATLANTA - Switching pancreatic cancer patients to the PARP inhibitor...
Credit: Caltech Devising the best treatment for a patient with cancer requires doctors to know something about the traits of...
ATLANTA -- The investigational anticancer therapeutic LOXO-195 (now known as BAY 2731954), which targets a family of proteins called TRKs,...
PITTSBURGH, April 1, 2019 - New research from the University of Pittsburgh School of Medicine and the UPMC Hillman Cancer...
By identifying signature of 16 disease-related microbial species, this international study with Brazilian participation may contribute to develop predictive tests...
Credit: University of Colorado Cancer Center A study by University of Colorado Cancer Center and Rain Therapeutics, Inc. presented at...
Credit: University of Colorado Cancer Center A cancer cell is like a racecar, speeding through the process of cellular replication....
Colorectal cancer is characterised by consistent changes in our gut bacteria across continents, cultures, and dietsCredit: EMBL in collaboration with...
Blood platelets which interact with liver cells and immune cells play a major role in the development of fatty liver...
Credit: University of Colorado Cancer Center Many cancers are relatively harmless at their site of origin, and it is only...
Researchers from the University of North Carolina Lineberger Comprehensive Cancer Center found preliminary evidence that measuring byproducts of the hormone...
ATLANTA -- A combination of the experimental histone deacetylase (HDAC) inhibitor entinostat with the anti-PD-1 therapeutic pembrolizumab (Keytruda) showed clinical...
Credit: Cazaux et al., 2019 In a study that will be published April 1 in the Journal of Experimental Medicine,...
ATLANTA -- Treatment with the FLT3-targeted therapeutic gilteritinib (Xospata) improved survival for patients with relapsed or refractory acute myeloid leukemia...
ATLANTA -- Vaccination with as few as four tumor antigens generated antigen-specific responses, reduced intestinal tumors, and improved survival in...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.